Monday, February 10, 2020

Study shows how extracellular vesicles help melanoma cells to spread

A new study from Finland sheds fresh light on how melanoma cells interact with other cells via extracellular vesicles they secrete. The researchers found that extracellular vesicles secreted by melanoma cells use the so-called hedgehog signaling pathway to intensify the malignant properties of the cells they are targeting. The discovery can help in the development of better treatment and diagnostics for melanoma. Published in Cellular and Molecular Life Sciences, the study was carried out in collaboration between researchers from the University of Eastern Finland and the University of Helsinki.

Many of the mechanisms regulating the function of our body have remained unchanged throughout evolution. This means that the same genes regulate the development and function of all multicellular animals. One example of such gene survival is the so-called hedgehog signaling pathway. The gene family associated with this signaling pathway gets its unique name from a mutation it caused in fruit fly larvae, making them look spiky, just like a hedgehog. The most common of the three hedgehog genes found in mammals, the Sonic hedgehog gene, was aptly named after the famous video game character. In mammals, members of the hedgehog gene family are essential regulators of fetal development, but they are also associated with stem cell division in later stages of development and even in adults. Recent studies suggest that their expression is also associated with many different types of cancer, including skin cancers. Melanoma is the most severe form of skin cancer, and it is becoming more and more common.


Extracellular vesicles carry signals between cells - and they can also carry packaged drugs

Traditionally, signaling in the body is thought to take place via freely circulating signals, such growth factors and hormones. According to a more recent view, however, it is believed that some signals are packaged for transportation to protect them against breakage and to ensure their delivery to the correct address. Extracellular vesicles are small, bubble-like packages made of cell membrane, serving as natural carriers of signals in the body. They regulate the function of the body already during the fetal stage, via breast milk and also later in life as our tissue regenerates. Cancer cells, too, use extracellular vesicles to deliver signals and to modify their environment, making it favorable to growth. Extracellular vesicles can also be used as diverse carriers of drugs to combat diseases and to repair tissue damage - and this is why they are being studied so actively at the moment.


In the newly published study, the researchers discovered a new link between extracellular vesicles and hedgehog molecules. They found that vesicles secreted by melanoma cells intensify the malignant properties of the cells they are targeting, such as division and spreading, via the hedgehog signaling pathway. The researchers used cultured human melanoma cells and normal skin cells, confirming their findings from the cell culture by analyzing tissue samples from patients with melanoma.

It is quite a coincidence that these signal-carrying vesicles originate from cells that are also known as hedgehog cells due to their microscopically small, spike-like protrusions. These protrusions, however, don't have anything to do with fruit fly larvae; instead, they are typically found in cells that are active in producing hyaluronan, the most common sugar molecule in the extracellular matrix. Hyaluronan also plays a key role in vesicle mediated signaling, as hyaluronan found on the surface of vesicles protruding from the cell surface facilitates their binding to the target cell."  Docent Kirsi Rilla, University of Eastern Finland

The hedgehog signaling pathway holds great promise as a target for drug therapy in melanoma and other cancers. The regulation mechanism now discovered by the researchers can be made use of in the development of better diagnostics and drug therapy for patients with melanoma.

Docent Rilla's research group has been studying the biology of extracellular vesicles since 2013.


This is only for your information, kindly take the advice of your doctor for medicines, exercises and so on.     
https://gscrochetdesigns.blogspot.com. one can see my crochet creations  
https://gseasyrecipes.blogspot.com. feel free to view for easy, simple and healthy recipes    
https://kneereplacement-stickclub.blogspot.com. for info on knee replacement
 

Labels: , , , , , , , , ,

Sunday, September 22, 2019

Brain cancer in kids can be treated with leukemia drug

In a recent study, researchers suggested a new use of leukemia drug, nilotinib to heal a deadly pediatric brain cancer called medulloblastoma.

In the study, published in September -- the team demonstrated how use of a single drug, in this case nilotinib, specifically targets cancer cells that have an abnormal activation of a cell communication system, called the Hedgehog pathway, via two different mechanisms, making it more effective and less toxic than combining drugs.


"We discovered a previously unknown activity of nilotinib that may be leveraged to treat a large fraction of cases of medulloblastoma, a type of childhood brain cancer," said senior author.

"While more research is needed, this pharmaceutical could potentially be used for several cancer types with an overactive cell-signaling pathway," added the author.


Several types of basal cell carcinoma, myeloid leukemia, rhabdomyosarcoma, pancreatic adenocarcinoma, glioblastoma and one-third of medulloblastoma cases have impairment in the Hedgehog signaling pathway, a key cellular system that regulates embryonic development and adult tissue regeneration.

As a result of this impairment, the cancer cells overproduce a cell-surface receptor called Smoothened. Malignancies with this abnormality account for a quarter of all cancer deaths said Abagyan.

"Only a fraction of patients with this subtype of medulloblastoma respond well to current therapies that only target Smoothened," said the author.

"Knowing that dysregulation of the Hedgehog pathway is important to the maintenance of cancer stem cells and that it plays a critical role in several cancers, we wanted to find a single drug that inhibits this pathway in addition to several other essential anti-cancer activities," added Abagyan.

In the study, researchers discovered that mice bearing human medulloblastoma tumours saw tumour growth reduced and no drug resistance occurring. Nilotinib simultaneously inhibits Smoothened and several protein kinases critical for tumor growth.



this is only for your information, kindly take the advice of your doctor for medicines, exercises and so on.   
https://gscrochetdesigns.blogspot.com. one can see my crochet creations 
https://gseasyrecipes.blogspot.com. feel free to view for easy, simple and healthy recipes    
https://kneereplacement-stickclub.blogspot.com. for info on knee replacement
 
 



Labels: , , , , , , , , , , , ,